Cytochrome b
Cytochrome *b (encoded in eukaryotes by the mitochondrial gene `MT-CYB` or `cob`) is an integral polytopic membrane hemoprotein that forms the catalytic core of Complex III (ubiquinol–cytochrome c oxidoreductase, or the cytochrome *bc*1...
Cytochrome b (encoded in eukaryotes by the mitochondrial gene MT-CYB or cob) is an integral polytopic membrane hemoprotein that forms the catalytic core of Complex III (ubiquinol–cytochrome c oxidoreductase, or the cytochrome bc1 complex, EC 1.10.2.2) in the inner mitochondrial membrane of eukaryotes and the plasma membrane of aerobic alpha-proteobacteria. Inside the homodimeric Complex III assembly (~480 kDa, 11 subunits per monomer in mammals), cytochrome b is the only subunit encoded by the mitochondrial genome (mtDNA); the remaining 10 subunits—including cytochrome c1 (CYC1) and the Rieske [2Fe-2S] iron-sulfur protein (UQCRFS1)—are encoded in the nucleus and imported from the cytosol.
Functionally, cytochrome b coordinates two non-covalently bound b-type protoheme IX prosthetic groups of unequal midpoint redox potential—low-potential heme bL (b566) near the intermembrane space (P-side) and high-potential heme bH (b562) near the mitochondrial matrix (N-side)—alongside two distinct quinone-binding pockets (Qo and Qi) to execute Peter Mitchell's protonmotive Q-cycle (1975): bifurcating the two electrons of ubiquinol (QH2) along divergent pathways so that 4 protons (H+) are translocated across the inner mitochondrial membrane for every 2 electrons transferred to cytochrome c. In parallel, because MT-CYB combines deep purifying structural constraint across its heme-ligating helices with high synonymous substitution rates at third codon positions, it serves alongside Cytochrome c Oxidase Subunit I (COX1) as one of the two primary mitochondrial barcode markers for vertebrate molecular systematics and phylogeography.
Structural Architecture and Dual Heme Coordination
High-resolution X-ray crystal structures (Xia et al., 1997; Iwata et al., 1998) demonstrate that mitochondrial cytochrome b (~379–380 amino acids, ~42.5 kDa in vertebrates) folds into a compact bundle of eight transmembrane α-helices (Helices A through H) connected by intermembrane-space (P-side) and matrix (N-side) loops, including the critical cd1/cd2 and ef surface helices containing the invariant PEWY motif (residues 270–273) that roofs the Qo active site:
| Structural Element / Cofactor | Helical Location & Axial Ligands | Midpoint Potential (Em,7) | Mechanistic Role in Complex III |
|---|---|---|---|
| Four-Helix Heme Core | Transmembrane Helices A, B, C, and D | Structural scaffold | Houses both hemes across the hydrophobic core of the inner mitochondrial membrane (~20 Å edge-to-edge iron distance) |
| Low-Potential Heme bL (b566) | Bis-histidine coordination by His83 (Helix B) and His182 (Helix D) near P-side | −30 to −90 mV | Accepts the second electron from nascent ubisemiquinone (Q•−) at the Qo site and transfers it ~12 Å across the membrane to heme bH |
| High-Potential Heme bH (b562) | Bis-histidine coordination by His97 (Helix B) and His196 (Helix D) near N-side | +30 to +90 mV | Transfers electrons from heme bL to ubiquinone (Q) or ubisemiquinone (Q•−) bound in the matrix-facing Qi pocket |
Qo (Quinol Oxidation) Pocket | Between Helices C/F, the PEWY ef-loop, and the Rieske [2Fe-2S] headgroup (P-side) | Bifurcation transition | Oxidizes ubiquinol (QH2 → Q + 2H+P), splitting its 2 electrons between the high-potential Rieske/Cyt c1 chain and the low-potential bL/bH chain (inhibited by Stigmatellin & Myxothiazol) |
Qi (Quinone Reduction) Pocket | Formed by Helices A, D, E and N-side loops adjacent to heme bH | ~+90 to +110 mV | Sequential two-step reduction of ubiquinone back to ubiquinol (Q + 2e− + 2H+N → QH2), consuming 2 protons from the mitochondrial matrix (inhibited by Antimycin A) |
Note: A homologous protein, cytochrome b6 (encoded by plastid petB alongside Subunit IV petD), forms the catalytic core of the cytochrome b6f complex in cyanobacterial and chloroplast thylakoid membranes, executing an analogous Q-cycle between plastoquinol (PQH2) and plastocyanin.
The Protonmotive Q-Cycle and Electron Bifurcation
Because coenzyme Q (ubiquinol, QH2) is a two-electron, two-proton carrier inside the lipid bilayer whereas cytochrome c is a water-soluble one-electron carrier in the intermembrane space, Complex III solves this stoichiometry mismatch while doubling its proton-pumping efficiency via the two-turnover Q-cycle:
- First Turnover at the
Qo Site (Bifurcated Oxidation of the FirstQH2): A molecule of ubiquinol (QH2) from the inner-membrane Q-pool docks into the P-sideQo pocket, forming a hydrogen-bonded bridge between His161 of the mobile Rieske[2Fe-2S]domain and Glu272 of the cytochrome bPEWYmotif.
- First Electron (High-Potential Branch): One electron is transferred to the Rieske
[2Fe-2S]cluster (Em ≈ +280 mV), releasing 2 protons (2H+P) into the intermembrane space. The reduced Rieske headgroup swings ~16 Å across a flexible hinge toward cytochrome c1 (Em ≈ +240 mV), which passes the electron to soluble cytochrome c (Em ≈ +254 mV). - Second Electron (Low-Potential Recycling Branch): The removal of the first electron leaves an unstable, low-potential ubisemiquinone radical (
Q•−) insideQo, which immediately transfers its second electron to heme bL (Em ≈ −50 mV) → heme bH (Em ≈ +50 mV) across the hydrophobic core of cytochrome b. At the matrix-facingQi pocket, heme bH reduces a bound oxidized ubiquinone (Q) to a stable ubisemiquinone (Qi•−).
- Second Turnover at the
Qo Site (CompletingQi Reduction): A secondQH2 molecule binds at theQo site and undergoes the same bifurcated oxidation: releasing another 2 protons (2H+P) into the intermembrane space, reducing a second molecule of cytochrome c via the Rieske/Cyt c1 branch, and sending a second electron through heme bL → heme bH to theQi pocket. There,Qi•− accepts the second electron and takes up 2 protons from the mitochondrial matrix (2H+N) to regenerate one molecule ofQH2:
QH2 + 2 Cyt c (Fe3+) + 2 H+N (matrix) → Q + 2 Cyt c (Fe2+) + 4 H+P (IMS)Thus, by recycling one of the two oxidized ubiquinol molecules at the Qi site, cytochrome b couples the net oxidation of 1 QH2 to the release of 4 protons into the intermembrane space (contributing 4 charges to the protonmotive force Δ*p* because 2 electrons move inward from P to N via bL → bH while 2 matrix protons are consumed at Qi).
Utility and Diagnostic Boundaries in Vertebrate Molecular Systematics
Since Thomas Kocher, Allan Wilson, and colleagues (1989) introduced universal vertebrate PCR primers (L14841 / H15149) targeting MT-CYB, the ~1,140 bp mitochondrial cytochrome b gene has served as one of the most widely sequenced markers in mammalian, avian, amphibian, and ichthyological phylogenetics, wildlife forensics, and species delimitation (Johns & Avise, 1998):
- Optimal Taxonomic Resolution Window (Intraspecific Phylogeography → Genus → Family): Across the eight transmembrane helices of
MT-CYB, first and second codon positions experience intense purifying selection (dN/dS = ω ≈ 0.02–0.05; the four axial histidine ligands His83, His97, His182, His196 and thePEWYmotif are invariant across Bilateria), whereas third codon positions substitute rapidly (transition/transversion ratio κ ≈ 8–15 in mammals), yielding an interspecific-to-intraspecific Kimura 2-Parameter (K2P) barcoding gap of 5×–18× across congeneric vertebrates (typical mammalian intraspecific divergence < 2% vs. sister-species divergence 4%–11%, supporting the Bradley & Baker 2001 genetic species concept). - Empirical Failure Boundaries and Rescue Protocols:
- Deep Transition Saturation (>30–50 Ma): Above the family/order level, third-codon transitions in
MT-CYBreach mutational saturation, compressing apparent branch lengths and triggering long-branch attraction unless recoded into amino acids or Dayhoff-6 physicochemical groups. - Nuclear Mitochondrial Pseudogenes (
NUMTs): Nuclear insertions ofMT-CYBthat have escaped mitochondrial purifying selection (ω → 0.85–1.00, accumulating frameshifts or vertebrate-vs-nuclearTGATrp/Stop codon mismatches) can co-amplify with short universal primers and masquerade as cryptic sister species unless filtered via full-length reading-frame translation, ω < 0.10 gates, and long-range mtDNA amplification.
Frequently Asked Questions
How does the antimalarial drug Atovaquone kill Plasmodium falciparum by targeting Cytochrome b?
Atovaquone (a hydroxynaphthoquinone structural analog of ubiquinone, combined clinically with proguanil as Malarone) selectively binds to the Qo pocket of Plasmodium falciparum mitochondrial cytochrome b, blocking ubiquinol oxidation and collapsing the parasite's inner mitochondrial membrane potential (ΔΨm). Whereas blood-stage P. falciparum parasites generate nearly all their ATP via cytosolic glycolysis rather than mitochondrial oxidative phosphorylation, they depend on Complex III to re-oxidize ubiquinol produced by mitochondrial dihydroorotate dehydrogenase (DHODH)—the rate-limiting fourth enzyme of de novo pyrimidine biosynthesis (which erythrocytes lack and parasites cannot salvage). Because human cytochrome b differs from Plasmodium cytochrome b at key residues lining the Qo pocket (whereas single point mutations at P. falciparum Tyr268Ser/Asn/Cys within the PEWY region confer high-level atovaquone resistance), atovaquone selectively starves the malaria parasite of pyrimidines for DNA replication with minimal toxicity to human mitochondria.
Why does Antimycin A increase mitochondrial superoxide (O2•−) production from Complex III?
Antimycin A (a Streptomyces macrolactone antibiotic) binds with nanomolar affinity to the matrix-facing Qi pocket of cytochrome b, blocking electron transfer from heme bH to ubiquinone. When Qi is blocked while ubiquinol (QH2) continues to arrive at the Qo site, both heme bH and heme bL become fully reduced ("backed up"). Consequently, when the next QH2 molecule transfers its first electron to the Rieske [2Fe-2S] cluster at Qo, the resulting ubisemiquinone radical (Qo•−) has nowhere to send its second electron because heme bL is already reduced; this prolongs the lifetime of Qo•− inside the P-side pocket, allowing it to react directly with dissolved molecular oxygen (O2) to generate superoxide radicals (O2•−) into both the intermembrane space and matrix. Conversely, Qo-site proximal inhibitors such as stigmatellin and myxothiazol prevent QH2 from entering Qo or transferring its first electron to the Rieske cluster, thereby suppressing Complex III superoxide generation.
References
- Mitchell, P. (1975). "Protonmotive redox mechanism of the cytochrome b–c1 complex in the respiratory chain: Protonmotive ubiquinone cycle." FEBS Letters, 56(1), 1–6. https://doi.org/10.1016/0014-5793(75)80098-680098-6)
- Xia, D., Yu, C. A., Kim, H., et al. (1997). "Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria." Science, 277(5322), 60–66. https://doi.org/10.1126/science.277.5322.60
- Kocher, T. D., Thomas, W. K., Meyer, A., et al. (1989). "Dynamics of mitochondrial DNA evolution in animals: Amplification and sequencing with conserved primers." Proceedings of the National Academy of Sciences, 86(16), 6196–6200. https://doi.org/10.1073/pnas.86.16.6196
- Johns, G. C., & Avise, J. C. (1998). "A comparative summary of genetic distances in the vertebrates from the mitochondrial cytochrome b gene." Molecular Biology and Evolution, 15(11), 1481–1490. https://doi.org/10.1093/oxfordjournals.molbev.a025875